Answer given by Ms Kyriakides on behalf of the European Commission (27.8.2021) 1. By concluding...
Today, the European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical...
With the increasing circulation of the Delta variant of SARS-CoV-2 in EU/EEA countries, the European Medicines Agency...
The use of antibiotics has decreased and is now lower in food-producing animals than in...
A stronger European Medicine Agency (EMA) with a reinforced transparency, participation, coordination and prevention –...
The Council has reached an agreement on draft rules to reinforce the role of the...
15 June 2021, 12:45 The Council has reached an agreement on draft rules to reinforce...
See question(s) : E-001513/2021 Source : © European Union, 2021 – EP Source: Answer to...
The European Medicines Agency has today started the rolling review of sotrovimab (VIR-7831), a monoclonal antibody developed...
News 20/04/2021 EMA confirms overall benefit-risk remains positive At its meeting of 20 April 2021,...
Today, as an immediate action under the HERA Incubator, the new European bio-defence preparedness plan...
MEPs will quiz EMA Executive Director Emer Cooke on the latest developments regarding the evaluation...
On Monday, Members of the Environment, Public Health and Food Safety Committee debated with experts...
MEPs will address their questions to experts on COVID-19 variants and the vaccines’ efficacy against...
DRAFT OPINION on the proposal for a regulation of the European Parliament and of the...
